Literature DB >> 12374798

Transcriptional activation of the MUC2 gene by p53.

Keizou Ookawa1, Toshihiro Kudo, Shu Aizawa, Hiroshi Saito, Shigeki Tsuchida.   

Abstract

MUC2 is one of the major components of mucins that provide a protective barrier between epithelial surfaces and the gut lumen. We investigated possible alterations of MUC2 gene expression by p53 and p21(Sdi1/Waf1/Cip1) in a human colon cancer cell line, DLD-1, establishing subclones in which a tetracycline-regulatable promoter controls exogenous p53 and p21 expression. MUC2 mRNA more significantly increased in response to p53 than to p21. Unexpectedly, MUC2 expression was also induced in human osteosarcoma cells, U-2OS and Saos-2, by exogenous p53. We next performed a reporter assay to test the direct regulation of MUC2 gene expression by p53. Deletion and mutagenesis of the MUC2 promoter region showed that it contains two sites for transactivation by p53. Furthermore, an electrophoretic mobility shift assay indicated that p53 binds to those elements. We analyzed MUC2 expression in other cell types possessing a functional p53 after exposure to various forms of stress. In MCF7 breast cancer and A427 lung cancer cells, MUC2 expression was increased along with the endogenous p53 level by actinomycin D, UVC, and x-ray, but not in RERF-LC-MS lung cancer cells carrying a mutated p53. These results suggest that p53 directly activates the MUC2 gene in many cell types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374798     DOI: 10.1074/jbc.M207986200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways.

Authors:  Kiyoshi Yamaguchi; Maria Cekanova; Michael F McEntee; Joo-Heon Yoon; Susan M Fischer; Ingrid B Renes; Isabelle Van Seuningen; Seung Joon Baek
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

2.  Poorly differentiated adenocarcinoma of the colon: subsite location and clinicopathologic features.

Authors:  Yasuo Imai
Journal:  Int J Colorectal Dis       Date:  2014-11-23       Impact factor: 2.571

3.  Ribosome biogenesis dysfunction leads to p53-mediated apoptosis and goblet cell differentiation of mouse intestinal stem/progenitor cells.

Authors:  A Stedman; S Beck-Cormier; M Le Bouteiller; A Raveux; S Vandormael-Pournin; S Coqueran; V Lejour; L Jarzebowski; F Toledo; S Robine; M Cohen-Tannoudji
Journal:  Cell Death Differ       Date:  2015-06-12       Impact factor: 15.828

4.  Evaluation of a Small Animal Irradiation System for Animal Experiments Using EBT3 Model GAFCHROMIC™ Film.

Authors:  Yasuyuki Shimizu; Hiroaki Akasaka; Daisuke Miyawaki; Naritoshi Mukumoto; Masao Nakayama; Tianyuan Wang; Saki Osuga; Sachiko Inubushi; Ryuichi Yada; Yasuo Ejima; Kenji Yoshida; Takeaki Ishihara; Ryohei Sasaki
Journal:  Kobe J Med Sci       Date:  2018-01-17

5.  Mucin 2 (MUC2) modulates the aggressiveness of breast cancer.

Authors:  Anna Astashchanka; Thomas M Shroka; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2018-10-13       Impact factor: 4.872

6.  Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma.

Authors:  Xiao-Dong Bu; Nan Li; Xiao-Qiang Tian; Li Li; Jin-Song Wang; Xiao-Jin Yu; Pei-Lin Huang
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

7.  Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis.

Authors:  Rodrigo Oliva Perez; Bárbara Helou Bresciani; Cláudio Bresciani; Igor Proscurshim; Desiderio Kiss; Joaquim Gama-Rodrigues; Diego Daniel Pereira; Viviane Rawet; Ivan Cecconnello; Angelita Habr-Gama
Journal:  Int J Colorectal Dis       Date:  2008-05-06       Impact factor: 2.571

Review 8.  MUC1 and MUC2 in pancreatic neoplasia.

Authors:  E Levi; D S Klimstra; A Andea; O Basturk; N V Adsay
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

9.  Impaired regulation of tumor suppressor p53 caused by mutations in the xeroderma pigmentosum DDB2 gene: mutual regulatory interactions between p48(DDB2) and p53.

Authors:  Toshiki Itoh; Cristin O'Shea; Stuart Linn
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  Inhibition of the p53 E3 ligase HDM-2 induces apoptosis and DNA damage--independent p53 phosphorylation in mantle cell lymphoma.

Authors:  Richard J Jones; Qing Chen; Peter M Voorhees; Ken H Young; Nathalie Bruey-Sedano; Dajun Yang; Robert Z Orlowski
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.